Caxton Associates LLP Takes $757,000 Position in The Cooper Companies, Inc. $COO

Caxton Associates LLP acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,594 shares of the medical device company’s stock, valued at approximately $757,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp lifted its position in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after buying an additional 207,195 shares during the period. Wellington Management Group LLP grew its holdings in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after acquiring an additional 2,231,568 shares during the last quarter. Sustainable Growth Advisers LP increased its stake in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after acquiring an additional 747,476 shares during the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of Cooper Companies by 108.2% during the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after acquiring an additional 2,089,763 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on COO shares. Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. BNP Paribas Exane dropped their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a research report on Monday, June 8th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Finally, Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Price Performance

COO stock opened at $70.31 on Monday. The stock’s 50 day moving average is $67.34 and its two-hundred day moving average is $72.12. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a market capitalization of $13.71 billion, a PE ratio of 59.58, a P/E/G ratio of 1.84 and a beta of 0.84. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.